US › Healthcare

Electromed Inc (ELMD)

US · Healthcare · Medical Devices

$42.16+1.39%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$18.6M

Revenue YoY

+18.4%

Net profit

$3.0M

Profit YoY

+58.8%

EPS

$0.35

EPS estimate

$0.24

Net margin

16.2%

EPS came in at 0.35 against a street estimate of 0.24 — a beat of 46.2%.

Key statistics

Market cap

$337.2M

P/E

34.8

Forward P/E

20.2

P/B

6.86

Book value

$5.94

EPS (TTM)

$1.17

52-week high

$47.40

52-week low

$18.14

50-day MA

$40.04

200-day MA

$29.83

Beta

0.50

Analyst view

Analysts rate Electromed Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $40.33.

Shareholding

Insiders

17.18%

Institutions

58.66%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Electromed Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.